Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06582771
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-30
Brief Title:
A Study of Sotorasib in People With Non-Small Cell Lung Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 2 Study of First-line Sotorasib for Patients With Advanced KRAS G12C-mutant Non-small Cell Lung Cancer
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The researchers are doing this study to see if sotorasib is a safe and effective treatment for people with advanced non-small cell lung cancer NSCLC with a KRAS G12C mutation who have not received treatment for their cancer since it became advanced Participants have not received a first-line therapy since their cancer became advanced
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None